Search results
Artisan International Fund Q1 2024 Commentary
Seeking Alpha· 40 minutes agoArtisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 days agoAbbVie’s top line is being driven by sales of new immunology drugs, Skyrizi and Rinvoq. The Zacks...
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s...
Fortune via Yahoo Finance· 20 hours ago“We believe that growth from ABBV’s ex-Humira business (primarily Skyrizi, Rinvoq, and aesthetics)...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 1 day agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
Big pharma: cautious optimism ahead of earnings season - analysts
Proactive Investors· 6 days agoLooking ahead to the pharmaceutical earnings season, UBS expressed cautious optimism when looking at...
FY2025 EPS Estimates for AbbVie Inc. (NYSE:ABBV) Lowered by Analyst
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Investment analysts at William Blair dropped their FY2025 EPS estimates for shares of AbbVie in a report released on Wednesday, April 17th. William Blair ...
AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors on Wednesday, April 17th. William ...
AbbVie (NYSE:ABBV) Shares Up 1.8%
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 1.8% on Thursday . The company traded as high as $167.44 and last traded at $167.14. BMO Capital Markets raised their price target on shares ...
